BMRN BioMarin Pharmaceuticals Inc PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

BioMarin Pharmaceuticals (BMRN) Stock: Buy, Sell, or Hold?

$56.70
-1.63 (-2.79%) â–ŧ
5d: +1.03% 30d: +2.83% 90d: -15.83%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (65%)
Quality Score
53/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$55.04 – $57.23
Position: SLIGHTLY HIGH
Forward P/E & Valuation
9.0x FAIR
vs 9.4x historical avg
Wall Street Target
$90.78
+60.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$52.00 / $59.51
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
ℹī¸ NEUTRAL: BMRN is fairly priced but lacks strong directional signals. At -1.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Nov 3, 2026 at $54.64 · last confirmed Nov 10, 2026

Strength: 4.5/10

Get Alerted When BMRN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$115.78
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$71.89
21.1% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.4x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: BMRN is currently trading at $56.70, which is considered slightly high relative to its 30-day fair value range of $55.04 to $57.23. The stock's valuation (Forward PE: 9.0) is in line with its historical norms (9.4). Remarkably, the market is currently pricing in an annual earnings decline of 1.6% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, BMRN is in a uptrend. Immediate support is located at $52.00, while resistance sits at $59.51.

Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $90.78 (+60.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $55.04 - $57.23
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 65.2%

Trading Range & Key Levels

30-Day Trading Range $55.04 - $57.23
Current vs Trading Range SLIGHTLY HIGH
Support Level $52.00
Resistance Level $59.51
Current Trend Uptrend
Technical data as of Nov 12, 2026

Protect Your Profits

Holding BMRN? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • NEUTRAL: Mixed technical signals (47/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 60.1% below Wall St target ($90.78)
  • WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 8.96
Wall Street Target $90.78 (+60.1%)
Revenue Growth (YoY) 32.0%
Earnings Growth (YoY) -81.3%
Profit Margin -0.5%
Valuation Discount vs History -1.6% cheaper
PE vs Historical 9.0 vs 9.4 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -1.6% (market-implied from PE analysis)
1-Year Target $55.79 (-2%)
2-Year Target $54.90 (-3%)
3-Year Target $54.02 (-5%)
3-Yr Target (if PE normalizes) (PE: 9→9) $56.64 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 108.9%) $423.94 (+648%)
Base: (SPY PE: 9.0, Growth: 108.9%) $191.36 (+238%)
Bear: (PE: 7.6, Growth: 108.9%) $162.66 (+187%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.0 to 9.4
Stabilization Target: $59.45 (+4.9%)
PE Expansion Potential: +4.9%
Share BMRN Analysis

Share this live BMRN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

Reddit StockTwits X / Twitter
bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (BMRN)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish trader on StockTwits mentioned margin calling short pigs for $BMRN, suggesting a potential short squeeze.
Key Retail Themes: Short squeeze
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 3:58 AM ET
Data refreshes hourly during market hours. Next update: 4:58 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is BMRN showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BMRN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
AXSM
Axsome Therapeutics Inc 		STRONG BUY
22 analysts 		$266 55 HOLD
SRRK
Scholar Rock Holding Corp 		STRONG BUY
18 analysts 		$70 52 HOLD
INCY
Incyte Corporation 		HOLD
28 analysts 		$132 50 HOLD
RAPP
Rapport Therapeutics, Inâ€Ļ 		STRONG BUY
16 analysts 		$64 48 HOLD
VRDN
Viridian Therapeutics Inc 		STRONG BUY
17 analysts 		$36 42 HOLD
AXSM Axsome Therapeutiâ€Ļ
55 HOLD
SRRK Scholar Rock Holdâ€Ļ
52 HOLD
INCY Incyte Corporation
50 HOLD
RAPP Rapport Therapeutâ€Ļ
48 HOLD
VRDN Viridian Therapeuâ€Ļ
42 HOLD

Advanced BMRN Option Strategies

Professional options setups generated by AI based on today's BMRN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive BMRN Research Pages
BMRN Technical Chart BMRN Price Prediction BMRN Intrinsic Value DCF BMRN Earnings Date Why is BMRN Moving Today? BMRN Investment Advisor BMRN Fair Price Analyzer BMRN Options Chain BMRN Options Advisor BMRN Options Analysis BMRN Competitors
Part B: Tradestie Flagship Market Scanners
Today's Best Signals (BMRN) Sector Rotation Monitor AI Supply Chain Money Flow Gamma Squeeze (GEX) Scanner Undervalued Stocks Scanner Insider Cluster Buying Reddit & WSB Sentiment Tracker Backtested Stock Scanner
Compare BMRN with Peers
BMRN vs INCY
Which one to buy?
BMRN vs ALNY
Which one to buy?
BMRN vs VRTX
Which one to buy?
BMRN vs REGN
Which one to buy?
BMRN vs BIIB
Which one to buy?
HALO vs BMRN
BMRN vs IGC
BMRN vs VNDA
Winner: BMRN
KRYS vs BMRN
BMRN vs IMUX
BMRN vs BBIO
ALNY vs BMRN
GMAB vs BMRN
APGE vs BMRN
PRAX vs BMRN
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals